Belluscura PLC (GB:BELL) has released an update.
Belluscura PLC has reported a record-breaking July with revenues of $708,000, surpassing June’s high, thanks to increasing demand for its portable oxygen concentrators, X-PLOR® and the newly launched DISCOV-R™. Anticipating continued sales momentum, the company projects FY24 revenues to reach $8 to $10 million, with an expected annualized revenue run rate of $14 to $16 million by year-end, positioning them to be EBITDA positive in Q1 FY25. The company is also exploring financial options to meet the high demand for the DISCOV-R™ as it gears up for its full commercial launch.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.
